|
FY2022
12 months to Dec 31, 2022
|
FY2021
6 months to Dec 31, 2021
|
|
|---|---|---|
| Cash Flows from Operating Activities | ||
| Net income (loss) | ||
| Adjustments to reconcile net income (loss) to net cash used in operating activities: | ||
| Gain on marketable securities (net), dividends and interest, held in Trust Account | ||
| Formation and operating expenses funded by note payable through Sponsor | ||
| Formation and operating expenses paid in exchange for Founder Shares | ||
| Changes in operating assets and liabilities: | ||
| Prepaid expenses | ||
| Other assets | ||
| Other current assets | ||
| Other non-current assets | ||
| Accounts payable | ||
| Accrued expenses | ||
| Net cash used in operating activities | ||
| Cash Flows from Investing Activities | ||
| Investment of cash into Trust Account | ||
| Purchase of marketable securities | ||
| Sale of marketable securities | ||
| Net cash used in investing activities | ||
| Cash Flows from Financing Activities | ||
| Proceeds from sale of Class A shares, gross | ||
| Proceeds from sale of Private Placement Warrants | ||
| Offering costs paid | ||
| Net cash (used in) provided by financing activities | ||
| Net change in cash | ||
| Cash - beginning of period | ||
| Cash - end of period | ||
| Supplemental disclosure of noncash investing and financing activities: | ||
| Offering costs included in accrued expenses | ||
| Offering costs paid through promissory note - related party | ||
| Offering costs paid through prepaid legal expense funded by sponsor | ||
| Deferred underwriting fees payable |
Loading...
